BIOMAT Database Logo BIOMAT Database Logo

Narcotic antagonists in the treatment of opioid dependence: review and commentary. 1979

R B Resnick, and E Schuyten-Resnick, and A M Washton

UI MeSH Term Description Entries
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003496 Cyclazocine An analgesic with mixed narcotic agonist-antagonist properties.
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

R B Resnick, and E Schuyten-Resnick, and A M Washton
Narcotic antagonists. An alternative for treating opioid dependence.
August 1982, American pharmacy,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence.
January 1995, The Journal of clinical psychiatry,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Narcotic antagonists in opiate dependence.
September 1970, Science (New York, N.Y.),
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid antagonists in the treatment of alcohol dependence.
December 2001, Current psychiatry reports,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid antagonists for the treatment of alcohol dependence.
November 2011, American family physician,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
November 2008, Current drug abuse reviews,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid antagonists and butorphanol dependence.
March 1993, Pharmacology, biochemistry, and behavior,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Do antagonists have a role in the treatment of opioid dependence?
April 2006, Addiction (Abingdon, England),
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid receptor signal transduction in narcotic tolerance and dependence.
January 1996, NIDA research monograph,
R B Resnick, and E Schuyten-Resnick, and A M Washton
Opioid antagonists for alcohol dependence.
January 2000, The Cochrane database of systematic reviews,
Copied contents to your clipboard!